Company History

March Successful issue of more than 26 million new ordinary shares on AIM
October Redx CEO shortlisted for the IoD SME Company Director of the Year
September Redx completes its move to Alderley Park now occupying the majority of the site's prime building - Block 33 - and bringing all subsidiaries together in one facility
February Redx CEO presented with 2016 Science and Innovation Award at North West IoD Director of the Year awards
November Redx wins Bionow Deal of the Year award and Dr Peter Jackson wins Outstanding Contribution award
September Cancer research collaboration with Horizon Discovery Group plc
May Redx Immunology launches at Alderley Park
March Redx admitted to AIM
October Redx completes demerger of its agrochemical business Redx Crop to focus on core human health activities
September Redx and AstraZeneca agree major research collaboration targeting genetic drivers of cancer tumour growth
March Redx and Pierre Fabre Laboratories agree major collaboration in cancer research
February Collaboration agreed with National Institute of Allergy and Infectious Diseases (NIAID) for flu programme
February IMI deal agreed for Gram-negative infection
November Redx named Bionow Company of the Year and one of its scientists, Dr Ralph Kirk, is named Promising Technologist of the Year
November Redx agrees pioneering £5.6m MRSA deal with NHS Royal Liverpool and Broadgreen University Hospitals Trust to work together on new drugs to combat the growing threat of anti-biotic resistance
October Redx CEO named as the Business Leader of the Year in the annual Liverpool Post Leaders Awards
June Redx named Knowledge Business of the Year at the Liverpool Post Regional Business Awards
May In-licence of cFMS programme from Pharmascience Inc
April Redx Anti-Infectives launches in Liverpool/Alderley Edge
October Redx awarded £4.7M Regional Growth Fund grant for new subsidiary Redx Anti-Infectives
October Redx nominated for Young Company of the Year at the Growing Business Awards
October Redx named North West's most innovative at the annual Institute of Directors Awards
September Redx signs licence agreement allowing Dishman Pharmaceuticals & Chemicals to use patented process technology
April Redx named Northwest Newcomer of the Year at the North West Business Masters
April Redx Oncology launches in Liverpool
November Redx named as Start-up Company of the Year at the annual BioNow Awards
October Redx secures £5.9m Regional Growth Fund grant to support the launch of Redx Oncology
June Redx wins the Liverpool Daily Post Regional Business Award for Knowledge Business of the Year
October Redx commences operations with equity funding to develop patent portfolio across 11 therapeutic areas